✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Multiple SclerosisInflammationBiomarkersNeurological ConditionsResearch Why This MattersCD29 protein identification as a key driver in...
Unlocking the Multifaceted Role of CB
The endocannabinoid system is a key homeostatic regulator that influences multiple physiological processes across nervous, immune, and metabolic systems in h…
Tecan webinar shares insights on salivary cortisol, from collection to confidence
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CortisolHpa AxisStress ResponseBiomarkersEndocrine Why This MattersSalivary cortisol measurement provides a non-invasive method to assess...
Variations in p21 protein may explain why some MS types progress faster
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Multiple SclerosisBiomarkersNeurodegenerationPersonalized MedicineDisease Progression Why This MattersUnderstanding protein variations that drive MS progression could...
Anticancer Potential of Cannabidiol in Renal Cell Carcinoma: Serum Modulation and Preliminary Mechanistic Insights.
CED Clinical Relevance #50Monitored Relevance Early-stage or contextual signal requiring further evidence before action. 🔬 Evidence Watch | CED Clinic CancerCbdOncologyBiomarkersClinical Study JournalJournal of clinical medicineStudy TypeClinical StudyPopulationHuman participants Why This MattersRenal cell carcinoma remains challenging...
Endocannabinoids and polyunsaturated fatty acids in early schizophrenia: Changes under antipsychotics and association with the response to treatment.
Evidence supports polyunsaturated fatty acid (PUFA) and endocannabinoid (eCB) metabolism dysregulation in schizophrenia. However, data on the topic are incon…
Pilot Study Finds Salivary Metabolite Shifts in Autistic Children Treated with Medical Cannabis—But Evidence Remains Preliminary
“Sixty-five potential cannabis-responsive biomarkers exhibiting a shift toward the TD physiological levels were identified in children with ASD after MC treatment.” — Authors’ caution that larger trials are needed is appropriate, but the term ‘Cannabis-Responsive’ implies causation the design cannot support.